Stratakis C A, Mastorakos G, Magiakou M A, Papavasiliou E C, Panitsa-Faflia C, Georgiadis E, Batrinos M L
Department Exp. Pharmacology, University of Athens, Greece.
Endocr Res. 1996 Aug;22(3):261-76. doi: 10.3109/07435809609030511.
Studies of the growth hormone (GH) secretory dynamics of children with normal and idiopathic short stature (ISS) have revealed that the regulation of the GH-somatomedin (GHS) axis can differ significantly among normal individuals. Information on the GH secretion in idiopathic tall stature (ITS) is scarce. We previously showed that the GH response to stimulation with GH-releasing hormone (GHRH) in male, late adolescents and young adults with ITS is significantly greater than that of their sex and age-matched controls of average height. In the present study, we studied the 24-hour (hr) GH, insulin-like growth factor-I and -II (IGF-I and -II), prolactin (PRL) and thyroid-stimulating hormone (TSH) secretion by every 30 minutes (min) sampling in 12 young, healthy male Greek army recruits. Group I [n = 6, age 22 + 1.4 years (y.), mean + standard deviation (SD)] had a height of 198.5 + 4.2cm, at least 3 SD's above the mean of the Greek male population. Group II (n = 6, age 20.5 + 1.05 y.) had a height of 169.2 + 3.4cm, within 2SD's of the normal mean. Serum IGF-I levels were determined in both unextracted and extracted samples. Our results indicated that the number of secretory bursts and the circadian panel of GH, IGF-I and -II, PRL and TSH were similar in the two groups. Both the amplitude of the secretory GH peaks (5.08 + 3.07 vs. 3.3 + 0.8 ng/ml, p = 0.19,) and the area under the curve (AUC) of the 24-hour GH secretion (9.8 + 5.5 vs. 6.6 + 1.3 ng/ml/hr, p = 0.2) were higher in group I than in group II, but the difference was not significant. A significant nocturnal increase of both IGF-I and -II levels was found only in extracted human plasma (p < 0.001), whereas measurements of IGF-I in unextracted samples failed to reveal circadian variation (p < 0.1). We conclude that no significant differences were found in this pilot study of the neurosecretory regulation of the GHS axis between individuals of tall and normal stature. A tendency for greater amount of GH secretion per secretory peak was found in persons with tall stature; however, this finding needs to be confirmed in a larger study. IGF-I and -II levels had a significant circadian variation with a large nocturnal surge, when measured in extracted plasma. The latter, might be explained by circadian variation of the circulating IGF-binding proteins and its detection appears to be method of extraction-dependent.
对正常身高和特发性矮小(ISS)儿童生长激素(GH)分泌动力学的研究表明,正常个体之间GH-生长调节素(GHS)轴的调节可能存在显著差异。关于特发性高身材(ITS)患者GH分泌的信息很少。我们之前表明,在青春期晚期和年轻成年男性ITS患者中,GH释放激素(GHRH)刺激引起的GH反应显著大于与其性别和年龄匹配的平均身高对照组。在本研究中,我们对12名年轻、健康的希腊男性新兵每30分钟进行一次采样,研究其24小时GH、胰岛素样生长因子-I和-II(IGF-I和-II)、催乳素(PRL)和促甲状腺激素(TSH)的分泌情况。第一组[n = 6,年龄22 ± 1.4岁(y.),均值 ± 标准差(SD)]身高为198.5 ± 4.2cm,比希腊男性人群均值至少高出3个标准差。第二组(n = 6,年龄20.5 ± 1.05 y.)身高为169.2 ± 3.4cm,在正常均值的2个标准差范围内。对未提取和提取后的样本均测定了血清IGF-I水平。我们的结果表明,两组中GH、IGF-I和-II、PRL以及TSH的分泌脉冲数量和昼夜节律情况相似。第一组中分泌性GH峰值的幅度(5.08 ± 3.07 vs. 3.3 ± 0.8 ng/ml,p = 0.19)和24小时GH分泌的曲线下面积(AUC)(9.8 ± 5.5 vs. 6.6 ± 1.3 ng/ml/hr,p = 0.2)均高于第二组,但差异不显著。仅在提取后的人血浆中发现IGF-I和-II水平有显著的夜间升高(p < 0.001),而未提取样本中IGF-I的测量未显示出昼夜变化(p < 0.1)。我们得出结论,在这项关于GHS轴神经分泌调节的初步研究中,身材高大和正常的个体之间未发现显著差异。身材高大的人每个分泌峰值的GH分泌量有增加的趋势;然而,这一发现需要在更大规模的研究中得到证实。当在提取后的血浆中测量时,IGF-I和-II水平有显著的昼夜变化,夜间有大幅升高。后者可能由循环IGF结合蛋白的昼夜变化来解释,其检测似乎依赖于提取方法。